The three-year-old telehealth startup bagged $200 million, catapulting it to unicorn status at a valuation of $1.5 billion. Ro plans to use the cash infusion to build out its tech capabilities and offer remote patient monitoring (RPM) tools for chronic disease management.
Read more here.
